About JAAS
publication date: Feb 5, 2009
About this journal.
The Journal of ApiProduct and ApiMedical Science (JAAS) will focus upon research being carried out on biologically relevant properties of bee products, and their scientific relevance in the fields of medicine, nutrition and healthcare.
There is extensive evidence that bee hive products have played an important role in the medical regimes of diverse civilizations since ancient times(see prologue in the first issue), but there is little objective experimental or
clinical evidence to explain the effectiveness of many of these remedies. Although honey is incorporated into contemporary wound care, the other hive products are largely ignored by modern physicians. Those ancient treatments have not been forgotten, however, and there is much interest in reviving them for modern patients, especially for those that fail to respond to current therapies.
The scope of this journal.
JAAS will cover research on the six main hive products:
honey, pollen, propolis, wax, royal jelly, bee venom.
It will publish research on the biologically relevant properties and substances of these products. Indeed, only the inclusion of such properties into standards can make their application in medicine successful. Unfortunately, advocates sometimes use hive products without a clear understanding of their effects or their precise mode of action.
To re-introduce different strategies into conventional medicine requires scientific data to demonstrate that improved outcomes will be established, because an evidenced-based approach was adopted during the 1990s. This journal aims to provide a forum where the efficacy and effectiveness of bee products with therapeutic properties can be presented, debated and evaluated using scientific principles.
Why produce yet another journal?
Increasing publicity is given to hive products but at present much of this information lacks a sound basis
in analytical science, and results that are published are spread throughout many journals. By providing the world with a single journal through which scientists can publish their peer reviewed findings on hive products, IBRA continues its mission of disseminating proven and practical information.
Who should be reading this journal?
JAAS will target a larger and more diverse readership reflecting the growing interest and potential offered by the products of the hive.
IBRA aims to capture the attention of researchers in the pharmaceutical and food industries, the medical and veterinary sciences, as well as expanding upon its more traditional area of support, apiculture.
How quickly will articles be published?
As a purely electronic journal the JAAS editorial team intend to have the peer reviewed articles available on-line as quickly as possible. 
IBRA already has a number of papers, each by a recognised world authority, which will set the tone, reputation and content of the journal.
Can IBRA guarantee quality articles?
The editorial team of renowned international
specialists, will only allow the publication of scientific research of a high standard and within
the scope of the journal. Neither the management of IBRA, nor the editors are prepared to have the reputation of the journal or IBRA tainted by
unfounded theories that may be linked to some of the more speculative applications of natural bee products.
